RENO yields 2000000.00% · JNJ yields 2.13%● Live data
📍 RENO pulled ahead of the other in Year 1
Combined, RENO + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RENO + JNJ for your $10,000?
Renovare Environmental, Inc., through its subsidiaries, provides environmental management solutions worldwide. The company's suite of technologies includes on-site biological processing equipment for food waste, patented processing facilities for the conversion of municipal solid waste into renewable fuel, and proprietary real-time data analytics tools to reduce food waste generation. It markets Revolution Series Digesters, an aerobic digestion technology solution for the disposal of food waste at the point of generation; and Mechanical Biological Treatment technology to process waste at the municipal or enterprise level. The company serves retail, healthcare, government, hospitality, education, food service, and other sectors, as well as food distributors, convention centers, hotels, restaurants, stadiums, municipalities, and academic institutions. The company was formerly known as BioHiTech Global, Inc. and changed its name to Renovare Environmental, Inc. in December 2021. Renovare Environmental, Inc. is headquartered in Chestnut Ridge, New York.
Full RENO Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.